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We recently determined that respiratory syncytial virus (strain A2) encodes a fourth unique envelope-asso-
ciated virion protein that has molecular weight of approximately 24,000, as estimated by gel electrophoresis.
The nucleotide sequence of the mRNA encoding this novel protein has now been determined from five cDNA
clones, including three that contain the complete mRNA sequence. The complete mRNA sequence is 957
nucleotides, exclusive of polyadenylate, and contains two partially overlapping open reading frames. The
5'-proximal open reading frame is favored for utilization by the criteria of the location and sequence of its
translational start site. Furthermore, the calculated molecular weight of the encoded protein, 22,153, is in
agreement with the previous estimate of 24,000 for the authentic protein identified by hybrid selection and in
vitro translation. The sequence of the predicted protein, now designated the 22K protein, contains 194 amino
acids, is relatively hydrophilic, and appears to be the most basic of the respiratory syncytial virus proteins. The
mRNA also contains a second, internal open reading frame which would encode a protein of 90 amino acids.
However, no evidence for this translation product is known. The first nine nucleotides in the mRNA sequence,
5'-GGGGCAAAU, are identical to the conserved sequence identified previously at the 5' termini of seven other
respiratory syncytial viral mRNAs; the sequence at the 3' end of the 22K mRNA, 5'. . . AGUUAUUU-polyad-
enylate, contains the elements of the previously identified 3'-terminal consensus sequence for respiratory
syncytial virus mRNAs, AGUuA(N)1-4polyadenylate (P. L. Collins, Y. T. Huang, and G. W. Wertz, Proc.
Natl. Acad. Sci. U.S.A. 81:7683-7687). In addition, we present and describe the intergenic sequence of a
dicistronic RNA derived from readthrough of the F and 22K protein genes.
Human respiratory syncytial (RS) virus is an enveloped,
cytoplasmic, RNA-containing paramyxovirus that is an im-
portant agent of respiratory tract disease (2). RS virus is
classified in a separate subgroup, pneumovirus, because of
differences in virion morphology and in the biological activ-
ities of the viral glycoproteins (21). More recently, as
described below, determination of the RS virus genetic map
and identification of RNA and protein gene products re-
vealed differences in gene number and genome organization
between the pneumovirus RS virus and other prototypic
paramyxoviruses, such as Sendai virus (11, 12, 25) and
Newcastle disease virus (3, 6).
The RS virus genome is a single negative strand of RNA
and has a molecular weight of approximately 5.0 x 106 to 5.6
x 106 (4, 19). cDNA cloning experiments have identified 10
unique, nonoverlapping viral mRNAs (4, 5). Intracellular
virus transcripts also include discrete species of polycis-
tronic readthrough RNAs (4, 5), as has been demonstrated
previously for the rhabdovirus vesicular stomatitis virus (15,
16) and for Newcastle disease virus (6, 40). Analyses of the
RS virus polycistronic RNAs by Northern blotting (4, 5),
together with UV mapping studies (7), determined the virus
transcriptional map.
Translation in vitro of individual viral nq.§NAs isolated by
gel electrophoresis (20) and by hybridiza!tion selection with
cDNA clones (4) has shown that each mRNA encodes a
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single species of protein. The detection of additional minor
proteins, possibly encoded by secondary reading frames (36,
39), has not been reproducible and remains to be investi-
gated further. These experiments (4, 20) identified the RNA
and protein products for the 10 viral genes. Seven of the 10
RS virus proteins have been identified unambiguously as
virion structural proteins: these are the large protein (L;
molecular weight, approximately 200,000); the major
glycoprotein (G; molecular weight, 84,000); the fusion
glycoprotein (F; molecular weight, 68,000); the major nucle-
ocapsid protein (N; molecular weight, 42,000); the nucleo-
capsid phosphoprotein (P; molecular weight, 34,000); the
matrix protein (M; molecular weight, 26,000); and the 22- to
25-kilodalton protein (22K) (10, 18, 30, 33, 34, 38, 41). Two
viral proteins, the 11K and 14K proteins, appear to be
nonstructural. The status as structural or nonstructural of
the remaining known protein, the 9.5K protein, is uncertain
(Y. T. Huang, P. L. Collins, and G. W. Wertz, Virus Res.,
in press). Six of the RS virus structural proteins, the L, G, F,
N, P, and M proteins, have apparent counterparts among
other paramyxoviruses. In contrast, the 22K protein lacks
known counterparts. Recently, virion dissociation experi-
ments in which nonionic detergent and increasing concen-
trations of salt were used identified the 22K protein as a
component of the virus envelope, with solubility character-
istics similar to those of the M protein (18).
As part of our efforts to characterize the structural com-
ponents of the RS virus virion, we describe here the con-
struction and sequencing of full-length cDNA clones of the
mRNA encoding the 22K protein. The 22K protein had been
previously designated VP25 (28, 30, 34, 41), VP6 (33), and
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FIG. 1. Restriction site map and strategy for cDNA sequencing. cDNAs 1-63, 22K-16, and 3-51 are drawn to scale, except part of 1-63
representing sequences unrelated to the 22K mRNA has been omitted, as indicated by double slash marks. The orientation from left to right
is 5' to 3' relative to the mRNA. The polydeoxyguanylate-polydeoxycytidylate tails and the polydeoxyadenylate tails at the 3' ends of 22K-16
and 3-51 are omitted. The arrows indicate the directions and extents of sequence determination in the message-sense (arrows above lines) and
antimessage strand (below lines). Double slash marks in certain arrows indicate where sequencing spanned the cDNA boundaries. Although
not shown, two other full-length cDNAs, cDNAs 22K-14 and 22K-15, were sequenced to an extent similar to that of 22K-16. The map location
of the DNA primer used for the primer extension experiments shown in Fig. 2 is indicated.
24K protein (4, 18). Here we use the designation 22K protein
in accordance with the calculated molecular weight deduced
from the nucleotide sequence.
MATERIALS AND METHODS
cDNA clones. All cDNAs were synthesized with intracel-
lular polyadenylated RNA as template and were cloned in
the PstI site of the Escherichia coli plasmid pBR322 by
polydeoxycytidylate * polydeoxyguanylate tailing. cDNAs
1-63 and 3-51 were constructed in earlier work (5). cDNAs
22K-14, 22K-15, and 22K-16 were isolated from a second
cDNA library constructed under the following conditions,
which were designed to maximize cDNA length (29). Polyad-
enylate [poly(A)]-selected RNA purified from eight 15-cm
dishes of RS virus-infected HEp-2 cells was reverse tran-
scribed in the presence of 0.8 mCi of [3H]dCTP (specific
activity, 400 mCi/mnmol; ICN Radiochemicals) in an 800-pJ
reaction mixture under previously described conditions (5)
with the addition of 80 pLg of actinomycin D per ml. After
incubation for 1 h at 43°C, the products were purified with
phenol-chloroform and precipitated with ethanol. The nucle-
ic acids were resuspended in water and incubated for 2 h at
37°C in the presence of 0.3 M NaOH (final volume, 300 [lI).
The mixture was neutralized by the additions of 25 pLI of 2.5
M Tris-hydrochloride (pH 7.6) and 30 pul of 2 M HCl and was
immediately passed through Sephadex G-200 with a column
buffer of 1 mM Tris-hydrochloride (pH 7.6). The cDNAs
contained in the leading edge of the void volume were
collected, yielding 8.5 pLg. Following the procedure of Land
et al. (29), we added homopolymeric dCMP tails in a 550-pu
reaction mixture containing 325 U of terminal transferase
(P-L Biochemicals). The reaction mixture was incubated at
15°C. Aliquots were withdrawn after 2.5 and 5 min and
adjusted to 10 mM EDTA, and the cDNAs were purified by
extraction with phenol-chloroform, followed by three rounds
of ethanol precipitation. Synthesis of the second cDNA
strand was performed in a 600-,u reaction mixture under the
conditions described above for reverse transcription of
mRNA, except the actinomycin D was omitted, the oligode-
oxythymidylate was replaced by 30 ,ug of oligodeoxyguanyl-
ate12_18 (P-L Biochemicals) per ml, and the reaction con-
tained 0.75 mCi of [a-32P]dCTP (specific activity, 3,000
Ci/mmol; Amersham Corp.). After incubation for 1 h at 43°C,
the reaction mixture was passed directly through Sepharose
6B, and the cDNAs in the void volume were recovered. To
obtain maximum completion of second-strand synthesis, we
assembled the cDNAs into a 400-pI reaction mixture con-
taining 10 mM Tris-hydrochloride (pH 7.6), 8 mM magne-
sium acetate, 70 mM KCl, 10 mM dithioerythritol, 0.5 mM
each deoxynucleotide, and 12 U of DNA polymerase I (Kle-
now fragment) (P-L Biochemicals). After incubation for 2 h
at 15°C, the reaction was terminated by the addition of
EDTA to 10 mM. The products were purified by extraction
with phenol-chloroform and passed through Sepharose 6B,
yielding 8 ,ug of double-stranded cDNA. Homopolymer
dCMP tails were added in a 600-pl reaction mixture under
the conditions described above, except incubation took place
at 30°C for 2.5 and 5 min. The reactions were terminated by
the addition of EDTA and by extraction with phenol-chlo-
roform, and the products were collected by ethanol precip-
itation. The cDNAs were then electrophoresed on a 1.5%
agarose gel under nondenaturing conditions in parallel with
end-labeled size markers prepared from HpaII digests of
miscellaneous viral cDNA clones from the cDNA library
previously described (5). The cDNAs and size markers were
visualized by autoradiography, gel bands containing the ap-
propriate cDNA size classes were excised, and the cDNAs
were recovered by electroelution. Previously described con-
ditions (5) were used for preparing PstI-digested, oligode-
oxyguanylate-tailed pBR322, for annealing plasmid and in-
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serts, and for transforming competent cells of Escherichia
coli HB101. cDNA clones of the 22K mRNA were identified
by colony hybridization with nick-translated cDNA 3-51 (5)
which had been purified from the vector by PstI digestion
and gel electrophoresis. These procedures followed conven-
tional protocols (31).
DNA sequence analysis. End-labeled DNA fragments were
prepared and analyzed by the chemical sequencing methods
of Maxam and Gilbert (32) with several modifications. Be-
fore the chemical reactions took place, DNAs were purified
by binding to and elution from NACS chromatography
matrix (Bethesda Research Laboratories). For the adenine-
plus-guanine reactions, DNA in 10 pul of water was mixed
with 25 ,u1 of formic acid (88%, reagent grade), incubated for
3 min at 20°C, and processed exactly as described for the
hydrazine reactions (32). The cleavage products were ana-
lyzed on 5, 6, 8, and 20% polyacrylamide sequencing gels
(0.35 mm by 25 by 40 to 100 cm). Except in the case of 20%
gels, gels were fixed with 10% acetic acid and dried before
autoradiography.
Primer extension. Recombinant plasmid 22K-16 (100 p-g)
was digested with HpaII and HaeIII, and the 179-base-pair
fragment spanning the cDNA terminus from base-pair 99 in
the 22K cDNA sequence to base pair 3660 in pBR322 was
isolated, 5' end labeled, digested with TaqI, and electropho-
resed on a nondenaturing 10% polyacrylamide gel. The
57-base-pair, double-stranded TaqI-HaeIII fragment, la-
beled at the 5' end of the antimessage-sense strand, was
recovered. For each experiment, approximately 20 pmol of
primer (2 x 106 dpm) was denatured by boiling for 2 min,
mixed with 20 p-g of intracellular viral mRNA in a 50-,ul
mixture containing 80% formamide, 40 mM PIPES [pipera-
zine-N,N'-bis(2-ethanesulfonic acid)] (pH 6.2), and 0.4 M
NaCl, and then incubated for 10 min at 65°C, 10 min at 54°C,
and 12 h at 42°C. The nucleic acids were precipitated twice
with ethanol, and the hybridized primers were extended by
reverse transcriptase in the presence or absence of dide-
oxynucleotides exactly as described previously (4a). After
incubation, nucleic acids were precipitated with ethanol and
analyzed on sequencing gels.
RESULTS AND DISCUSSION
cDNA sequencing. The restriction site map and strategy for
sequencing cDNAs of the 22K mRNA are shown in Fig. 1.
Most of the sequence was determined from the partial
cDNAs 1-63 and 3-51, which were constructed in previous
work (5). Sequencing was completed on three approximately
full-length cDNAs, 22K-14, 22K-15, and 22K-16, synthe-
sized as described above. The cDNA end that is 5' relative
to the mRNA was identified by primer extension experi-
ments described below. The 3' end was identified by the
detection of terminal polydeoxyadenylate (13 to 23 residues)
in cDNAs 3-51, 22K-14, and 22K-16. cDNA 22K-16 was
found to contain the complete mRNA sequence. Interest-
ingly, (see below), cDNA 1-63 was found to be a partial copy
of a dicistronic readthrough RNA with the structure 5' F
mRNA-intergenic sequence-22K mRNA 3'.
Mapping the 5' mRNA end. To precisely map the 5' end of
the 22K mRNA, we hybridized a 5' end-labeled DNA primer
(see above) to intracellular mRNA and extended to the 5'
mRNA end under conditions of partial chain termination
(Fig. 2A). In previously published work (14), reverse trans-
criptase was shown to add an additional nucleotide to the




























FIG. 2. Mapping and sequencing of the 5' end of the 22K
mRNA. (A) A 5'-end-labeled DNA primer was hybridized to intra-
cellular mRNA and extended to the 5' mRNA end by reverse
transcriptase (lane 1). The position of the major extension product
representing the authentic mRNA end is marked with a closed
arrow, the open arrow indicates an artifactual end addition product
described in the text. Lanes G, A, T, and C represent parallel
reactions performed under conditions of partial chain termination
with the appropriate dideoxynucleotide. The products were ana-
lyzed on an 8% sequencing gel. The deduced mRNA sequence in
antimessage sense is shown. The fifth and sixth nucleotides (under-
lined) from the mRNA end could not be identified unambiguously by
this experiment, but were identified as described in the legend to
Fig. 2B. (B) The 5' end-labeled primer was elongated on mRNA,
and the extended product was purified by gel electrophoresis and
sequenced by the chemical method. The cleavage products were
analyzed on an 8% sequencing gel and visualized with an intensify-
ing screen. The lane headings denote the reaction specificities: lane
G, guanine; lane A, guanine plus adenine; lane T, cytosine plus
thymine; lane C, cytosine. The deduced nucleotide sequence (anti-
message sense) is shown.
copying of the mRNA cap. A similar artifactual product
(Fig. 2A, open arrow) was evident in the experiment shown
in Fig. 2A and was discounted. The deduced sequence of the
5' mRNA end was determined to be, in mRNA sense, 5'
NGGGCAAAU. The terminal nucleotide could not be iden-
tified by this method because all four dideoxynucleotide
reactions terminate nonspecifically at the mRNA end. To
identify the terminal nucleotide, we purified the fully elon-
gated primer by gel electrophoresis and sequenced it by the
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GGG GCA AAT ATG TCA CGA AGG AAT CCT TGC AAA TTT GAA ATT CGA GGT CAT TGC TTA AAT GGT AAG AGG TGT CAT
Met Ser Arg Arg Asn Pro Cys Lys Phe Glu Ile Arg Gly His Cys Leu Asn Gly Lys Arg Cys His
TTr AGT CAT AAT TAT TTT GAA TGG CCA CCC CAT GCA CTG CTT GTA AGA CAA AAC TTT ATG TTA AAC AGA ATA CTT
Phe Ser His Asn Tyr Phe Glu Trp Pro Pro His Ala Leu Leu Val Arg Gln Asn Phe Met Leu Asn Arg Ile Leu
AAG TCT ATG GAT AAA AGT ATA GAT ACC TTA TCA GAA ATA AGT GGA GCT GCA GAG TTG GAC AGA ACA GAA GAG TAT
Lys Ser Met Asp Lys Ser Ile Asp Thr Leu Ser Glu Ile Ser Gly Ala Ala Glu Leu Asp Arg Thr Glu Glu Tyr
G CT CTT GGT GTA GTT GGA GTG CTA GAG AGT TAT ATA GGA TCA ATA AAC AAT ATA ACT AAA CAA TCA GCA TGT GTT
Ala Leu Gly Val Val Gly Val Leu Glu Ser Tyr Ile Gly Ser Ile Asn Asn Ile Thr Lys Gln Ser Ala Cys Val
GCC ATG AGC AAA CTC CTC ACT GAA CTC AAT AGT GAT GAT ATC
Ala Met Ser Lys Leu Leu Thr Glu Leu Asn Ser Asp Asp Ile
CCC AAG ATA AGA GTG TAC AAT ACT GTC ATA TCA TAT ATT GAA
Pro Lys Ile Arg Val Tyr Asn Thr Val Ile Ser Tyr Ile Glu
CTG TTA AAA AGA TTG CCA GCA GAC GTA TTG AAG AAA ACC ATC
Leu Leu Lys Arg Leu Pro Ala Asp Val Leu Lys Lys Thr Ile
ATC AAC AAC CCA AAA GAA TCA ACT GTT AGT GAT ACA AAT GAC
Ile Asn Asn Pro Lys Glu Ser Thr Val Ser Asp Thr Asn Asp
TCC TTG TAG TAT AAC TTC CAT ACT AAT AAC AAG TAG ATG TAG
TTT CAA TCA AAA CAA CCC AAA TAA CCA TAT GTA CTC ACC GAA
AGA ATT GAT TGA CAC AAT TCA AAA TTT TCT ACA ACA TCT AGG
AGr GTC ATA ACA CTC AAT TCT AAC ACT
AAT GGA TCC CAT TAT TAA TGG AAA TTC
AAA AAG CTG AGG GAC AAT GAA GAG CTA AAT TCA
Lys Lys Leu Arg Asp Asn Glu Glu Leu Asn Ser
AGC AAC AGG AAA AAC AAT AAA CAA ACT ATC CAT
Ser Asn Arg Lys Asn Asn Lys Gln Thr Ile His
AAA AAC ACA TTG GAT ATC CAT AAG AGC ATA ACC
Lys Asn Thr Leu Asp Ile His Lys Ser Ile Thr
CAT GCC AAA AAT AAT GAT ACT ACC TGA CAA ATA
His Ala Lys Asn Asn Asp Thr Thr****
AGT TAC TAT GTA TAA TCA AAA GAA CAC ACT ATA
TCA AAC ATT CAA TGA AAT CCA TTG GAC CTC TCA
TAT TAT TGA GGA TAT ATA TAC AAT ATA TAT ATT
CAC CAC ATC GTT ACA TTA TTA ATT CAA ACA ATT CAA GTT GTG GGA CAA














FIG. 3. Complete nucleotide sequence of the 22K mRNA and the predicted protein sequence encoded by the 5'-proximal open reading
frame.
plete sequence of the 5' mRNA end is, in mRNA sense, 5'
GGGGCAAAU.
Nucleotide sequence of the 22K mRNA. The complete
sequence of the 22K mRNA, exclusive of poly(A), contains
957 nucleotides (Fig. 3). The first nine nucleotides of the
sequence, 5' GGGGCAAAU, are identical to the consensus
sequence that has been identified (4a) at the 5' termini of the
seven other RS virus mRNAs whose sequences are availa-
ble: the G, 1A, 1B, and 1C mRNAs (P. L. Collins and G. W.
Wertz, submitted for publication; unpublished data), F
mRNA (4a), M mRNA (36), and N mRNA (9; unpublished
results). In addition, the 3' end of the 22K mRNA,
5'. . .AGUUAUUU-poly(A), is consistent with the consen-
sus sequence, 5'. . .AGUAA(N)1 4poly (A), previously iden-
tified for the seven mRNAs listed above (4a). Thus, as is the
case for Sendai virus and vesicular stomatitis virus (11, 13,
14, 35, 37), the termini of RS virus genes contain conserved
1
2
consequences. This contradicts the previous conclusion that
RS virus mRNAs lack conserved termini (9, 36).
The 22K mRNA contains two major, partially overlapping
open reading frames (Fig. 4). For eucaryotic mRNAs in
general, a published survey of known translational start sites
shows that (i) translation usually begins at the first, 5'-
proximal AUG, and (ii) the presence of a purine, but not a
pyrimidine, in the -3 position correlated positively with
utilization (22-24). By both criteria, the translation start site
for the 5'-proximal open reading frame, 5'-AAAUAUGU
(nucleotides 6 through 13), has a structure that is consistent
with utilization. This open reading frame encodes a poly-
peptide of 194 amino acids with a calculated molecular
weight of 22,154 (Table 1). This is in good agreement with
the molecular weight of 24,000 estimated by gel electropho-
resis of the product identified by hybrid selection and in vitro
translation (4). Thus, the available evidence indicates that
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FIG. 4. Map of methionine codons (upper vertical lines) and translational stop codons (lower vertical lines) in the three reading frames of
the 22K mRNA. The reading frames 1, 2, and 3 start with, respectively, the first, second, and third nucleotides in the sequence. The two
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TABLE 1. Amino acid compositon of the 194-amino acid (22,
154-dalton) protein product encoded by 22K mRNA





















the 5'-proximal open reading frame encodes the previously
identified translation product of the 22K mRNA.
In contrast, the location and structure of the translational
start site for the internal open reading frame,
5'. . .ACAAAUGA (nucleotides 559 through 566), are incon-
sistent with utilization. This open reading frame would
encode a polypeptide of 90 amino acids, but there is pres-
ently no evidence that the internal open reading frame is
utilized. If the internal open reading frame is not used, then
363 nucleotides at the 3' end of the 22K mRNA are non-
translated. This would be unusual in comparison with the
shorter nontranslated regions characteristic of other para-
myxoviral, rhabdoviral, and influenza viral mRNAs se-
quenced to date. The possibility of an RNA splicing mech-
anism for expression of the internal open reading frame, as
has been demonstrated for the M and NS mRNAs of
influenza virus (26, 27), has not been ruled out but currently
lacks experimental support because (i) RS virus transcrip-
tion and replication occurs in the cytoplasm and appears to
be independent of the cell nucleus, and (ii) truncated ver-
sions of the 22K mRNA were not detected in Northern blot
experiments (5). Recently, it was shown that eucaryotic
ribosomes that encountered a translational stop codon could
reinitiate at a nearby, downstream translational start site
(24). The demonstration of this reinitiation event suggested
an alternate mechanism for expression of the internal open
reading frame: ribosomes that terminate translation at nu-
cleotides 592 through 594 at the end of the 5'-proximal open
reading frame could reinitiate at nucleotides 650 through 652
and direct translation of the downstream two-thirds of the
internal open reading frame to generate a polypeptide of 61
amino acids. No such protein has been reported, but a
careful investigation has not been performed, and the reini-
tiation event might be infrequent but nonetheless authentic.
These issues will require further investigation.
The two overlapping open reading frames described here
for the 22K mRNA could have been generated artifactually if
base deletions or insertions had occurred in the middle of a
larger open reading frame during the synthesis or cloning of
cDNA 3-51 or during the synthesis of the individual mRNA
transcript represented by the clone. To investigate this
possibility, we examined the sequence representing the
overlap and flanking regions in two independent cDNAs,
cDNAs 22K-15 and 22K-16 (Fig. 1). The sequencing spanned
the overlap as well as several upstream translational stop
codons in frames 2 and 3 and thus covered the region where
the postulated insertion or deletion could have occurred.
The results confirmed the sequence of cDNA 3-51. This
provided evidence that the mRNA structure shown in Fig. 4
is authentic.
The 22K mRNA and its encoded protein have been
identified only recently as unique viral gene products (4, 5).
The deduced nucleotide and amino acid sequences pre-
sented here lack extensive homology with other available RS
virus sequences, confirming that the 22K gene is unique and
nonoverlapping.
Structure of the 22K protein. The amino acid sequence
shown in Fig. 3 shows that the 194-amino acid 22K protein is
rich in charged amino acids (59 residues), with a theoretical
charge of +9.5 at neutral pH, assuming a contribution of +1
for arginine and lysine, +0.5 for histidine, and -1 for
aspartate and glutamate. The prediction that the 22K protein
is highly basic is in agreement with results from gel elec-
trophoresis in the presence of a pH gradient (8). The
predicted protein contains two clusters of basic amino acids:
amino acids 3 through 48 include 13 basic and two acidic
residues, and amino acids 139 through 162 include nine basic
and one acidic residues. There are also two clusters of acidic
residues: amino acids 51 through 71 include two basic and
seven acidic residues, and amino acids 105 through 119
include three basic and six acidic residues. The remaining
charged amino acids are scattered throughout the sequence.
The 22K protein has been shown to be associated with the
virus envelope and to resemble the M protein in its sensitiv-
ity to solubilization with nonionic detergent and high salt
(18). The exact nature, however, of the association of the
22K protein relative to the virion envelope remains to be
established. To search for possible hydrophobic domains in
the polypeptide chain, we prepared a plot of local hydropho-
bicity (17) versus sequence position (Fig. 5). This demon-
strated that the 22K protein is relatively hydrophilic and
contains only three moderately hydrophobic regions (amino
acids 21 through 37, 72 through 91, and 127 through 135).
Amino acids 72 through 91 are the best candidates for direct
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FIG. 5. Plot of hydrophilic (areas above line) and hydrophobic
(areas below line) regions in the 22K protein. A window of 10 amino
acids was used to calculate the local hydrophobicity of each position
on the basis of published hydrophobicity values (17) (local hydro-





70 COLLINS AND WERTZ
I 10 20 30 40
. A.GUUU AUAGU UAUAU AAAAC ACAAU UGAAU GCCAG AUUAA CUUAC CAUCU GUAAA AAUGA AAACU GGGGC AAAUA UGUCA ...
F mRNA 22K mRNA
FIG. 6. Nucleotide sequences of the intergenic and flanking sequences in a polycistronic readthrough RNA. The sequence, written 5' to
3' (left to right) in mRNA sense, was deduced as described in the text by DNA sequencing of cDNA 1-63. Sequences that represent the 3'
end of the F mRNA (4a) and the 5' end of the 22K mRNA (Fig. 3) are underlined. The intergenic sequence is numbered.
phobic and only 1 is charged. The 22K protein lacks an
NH2-terminal hydrophobic signal peptide and, in general,
the amino acid sequence provides no compelling evidence
for insertion into membranes.
The 22K protein was not labeled detectably in infected
cells with mannose, glucosamine, or Pi (1, 28, 33), and the
22K protein extracted from infected cells or virions has the
same electrophoretic mobility and peptide map as the 22K
protein synthesized in vitro (4, 18). Thus, there is no
evidence of post-translational processing.
Nucleotide sequence of a dicistronic RNA. cDNA 1-63 was
previously identified as a cDNA of the F mRNA on the basis
of high-stringency hybrid selection and translation in vitro
(4). Subsequently, hybridization of cDNA 1-63 with North-
ern blots of intracellular viral RNA under conditions of low
stringency showed that the clone hybridized strongly with
the F mRNA, but also hybridized detectably with the 22K
mRNA (data not shown). This suggested that cDNA 1-63 is
a partial cDNA of a dicistronic transcript, which was con-
firmed by DNA sequencing and comparison with the nucle-
otide sequences of the F mRNA (4a) and 22K mRNA (Fig.
3). The sequence analysis showed that the message-sense
strand ofcDNA 1-63 contains 1,590 nucleotides representing
the 3' end of the F mRNA followed by four A residues, an
intergenic sequence of 46 nucleotides, and 235 nucleotides
representing the 5' end of the 22K mRNA. The intergenic
and flanking sequences are shown in Fig. 6. The 3' end of the
F mRNA and 5' end of the 22K mRNA are represented in
cDNA 1-63 exactly, without deletion or rearrangement. This
supports the conclusion that the RNA represented by cDNA
1-63 is a readthrough transcript at the F and 22K genes and
contradicts previous suggestions (9, 36) that the readthrough
RNAs are transcribed from aberrant deletion mutants lack-
ing regulatory signals at the gene boundaries. The structure
of the dicistronic RNA, 5' mRNA-intergenic sequence-22K
mRNA, is in agreement with the viral transcriptional map (4,
5, 7).
We are presently sequencing intergenic regions in RS
virus genomic RNA. However, the poor growth of RS virus
in tissue culture and the instability of the virion have
presented formidable obstacles to this analysis. Therefore,
we have analyzed RNA polytranscripts as an alternate,
concurrent approach to investigating intergenic sequences.
Analogous polytranscripts had been analyzed previously for
vesicular stomatitis virus (15, 16) and Sendai virus (4). For
these two viruses, RNA sequencing showed that the interge-
nic sequences in the polytranscripts were exact complemen-
tary copies of the intergenic sequences in the genomic RNA,
except that in the case of the vesicular stomatitis virus
polytranscripts the intervening poly(A) tract was much longer
than the seven residues encoded directly in the genome (14,
16). In the RS virus polytranscript analyzed here (Fig. 6), the
upstream cistron is followed by four A residues. For four
other polytranscripts analyzed to date, the upstream cistrons
are followed by four to six A residues (data not shown).
Thus, the RS virus polytranscripts lack the long intervening
poly(A) tract characteristic of vesicular stomatitis virus
polytranscripts (15, 16) and instead have short oligoadenyl-
ate tracts similar to those of Sendai virus (14), although
unlike Sendai virus, the RS virus oligoadenylate tracks vary
in length. The intergenic structure that follows the four A
residues (Fig. 6) is surprisingly long, containing 46 nucleo-
tides, and therefore has no apparent similarity to the dinu-
cleotide and trinucleotide intergenic regions of vesicular
stomatitis virus and Sendai virus, respectively. Surprisingly,
the intergenic sequence shown in Fig. 6 also has no apparent
resemblance to the four other sequenced RS virus polytran-
script intergenic sequences, which contain 1, 9, 19, and 26
nucleotides (data not shown). Two of these intergenic se-
quences were determined by direct sequencing of intracel-
lular RNA (data not shown), indicating that, despite the lack
of sequence conservation among different polytranscripts,
each polytranscript population is homogeneous. It will be
important to extend these preliminary observations by direct
analysis of genomic RNA.
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